JUMBO-TIMI 26 evaluated the efficacy and safety of prasugrel, a novel thienopyridine, compared to clopidogrel in patients undergoing PCI. MAIN RESULTS: Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO) TIMI 26 trial Circulation. 2005 … Continue reading JUMBO-TIMI 26